Sage Therapeutic Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sage Therapeutic Stock Summary

Sage Therapeutic competes with Apellis Pharmaceuticals, Terns Pharmaceuticals, Day One, Blueprint Medicines, and Amylyx Pharmaceuticals. Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Sage Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 471 people.

Sage Therapeutic Key Financial Ratios

Sage Therapeutic Key Balance Sheet Accounts

Sage Therapeutic Key Cash Accounts

Sage Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sage Therapeutic's current stock value. Our valuation model uses many indicators to compare Sage Therapeutic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sage Therapeutic competition to find correlations between indicators driving Sage Therapeutic's intrinsic value. More Info.Sage Therapeutic is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Sage Therapeutic's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Sage Therapeutic by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Sage Therapeutic Systematic Risk

Today, most investors in Sage Therapeutic Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sage Therapeutic's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sage Therapeutic growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sage Therapeutic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sage Therapeutic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sage Therapeutic based on widely used predictive technical indicators. In general, we focus on analyzing Sage Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sage Therapeutic's daily price indicators and compare them against related drivers.

When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.